Wall Street Journal
Johnson & Johnson’s manufacturing-quality lapses continued, as the company said it would recall HIV/AIDS drug Prezista in several countries after discovering trace amounts of a chemical that emitted offensive odors.
J&J’s Janssen-Cilag International unit said it had received four consumer reports of musty or moldy odors, which affected products sold in the U.K., Ireland, Germany, Austria and Canada. The company is working with regulatory authorities in those countries.
J&J said in a press release it would recall and replace any affected bottles of Prezista remaining in the marketplace, estimated to be fewer than 2,000 in countries where recalls have been initiated.